TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation.
about
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular DiseaseNon-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in miceTRAIL modulates the immune system and protects against the development of diabetes.Impaired adipose tissue expandability and lipogenic capacities as ones of the main causes of metabolic disorders.TNF-related apoptosis-inducing ligand promotes human preadipocyte proliferation via ERK1/2 activation.TRAIL (TNF-related apoptosis-inducing ligand) inhibits human adipocyte differentiation via caspase-mediated downregulation of adipogenic transcription factors.Nicotine in combination with a high-fat diet causes intramyocellular mitochondrial abnormalities in male miceSurvivin, a key player in cancer progression, increases in obesity and protects adipose tissue stem cells from apoptosis.Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System.Trail (TNF-related apoptosis-inducing ligand) induces an inflammatory response in human adipocytes.TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications.Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women.TRAIL attenuates RANKL-mediated osteoblastic signalling in vascular cell mono-culture and co-culture models.The long and winding TRAIL to weight loss.TRAIL reduces impaired glucose tolerance and NAFLD in the high-fat diet fed mouse.Circulating level of TRAIL concentration is positively associated with endothelial function and increased by diabetic therapy in the newly diagnosed type 2 diabetic patients.The levels of circulating TRAIL at the onset of type 1 diabetes are markedly decreased in patients with ketoacidosis and with the highest insulin requirement.TRAIL Deletion Prevents Liver, but Not Adipose Tissue, Inflammation during Murine Diet-Induced Obesity.
P2860
Q26747224-1C59615F-5365-4A72-9C97-694A8B08FB11Q33689591-184078B6-82C3-4C22-94D3-74C726429BA5Q35155962-A4031A7B-AF07-4D0C-934E-127BAFDF15FCQ35438444-422FBB2F-4E61-417A-859F-9AEE132936B5Q35774778-781E27DB-440C-46BD-8FD7-A43B7FE48AC9Q37465838-E637AEAD-D750-4B1C-B80B-0FB0885CB2BAQ37594077-B0321B55-1486-4ED8-BE80-82CF53A8ED3CQ38778130-6AB1EE0D-17AF-4577-89FA-78236979FF11Q40041063-13EA360B-94FE-454C-9D0D-6F1D07DCBD9DQ41051062-555FAD20-CF0C-4076-A84D-B8170E99FFCAQ41123139-C4A4797A-652C-4986-8EE4-B92D2A3D0714Q43379345-2FB57F94-DEC8-4077-AF78-09CD12964D34Q47128807-E39DB3B8-84C8-43CA-8F8E-C4B759753870Q47301573-5EF0F064-6F50-46F4-A389-3E5FEF1D88C3Q47372528-0B2E599C-759F-4F79-BFE3-AA5D0274E8ACQ47819776-197CD70A-E2AC-40B9-A3FA-3EEA6A58F469Q47832405-470B8A49-A6E7-4F52-96DB-E977046A3833Q52745207-EBFB14AE-992E-4B8B-BDC7-B6CAAC48DB14
P2860
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
TNF-related apoptosis-inducing ...... ity and systemic inflammation.
@en
TNF-related apoptosis-inducing ...... ity and systemic inflammation.
@nl
type
label
TNF-related apoptosis-inducing ...... ity and systemic inflammation.
@en
TNF-related apoptosis-inducing ...... ity and systemic inflammation.
@nl
prefLabel
TNF-related apoptosis-inducing ...... ity and systemic inflammation.
@en
TNF-related apoptosis-inducing ...... ity and systemic inflammation.
@nl
P2093
P50
P356
P1433
P1476
TNF-related apoptosis-inducing ...... ity and systemic inflammation.
@en
P2093
Christos Tikellis
Mark E Cooper
Riccardo Candido
P304
P356
10.1042/CS20120176
P407
P577
2012-11-01T00:00:00Z